Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 Combined with Vedolizumab for Moderate Ulcerative Colitis
NCT06609447Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
A Phase 4 trial of VSL#3 in ulcerative colitis (UC), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Sep 2024; status: recruiting.
02
Drugs
VSL#3
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06609447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06609447.